Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 119.4% | 76.9% | 36.1% | 99.0% | 135.7% | 151.3% | 123.5% | (25.4%) | (21.5%) | (61.9%) | (592.4%) | (3,735.1%) | 123.7% | 309.7% | 180.6% | 151.8% | 153.2% | 86.7% | 107.1% | (1,277.1%) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 246.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Amedisys, Inc. have been 908.0% over the past three years, and 729.0% over the past five years.
As of today, Amedisys, Inc.'s FCF to Net Income is 246.9%, which is higher than industry median of 40.8%. It indicates that Amedisys, Inc.'s FCF to Net Income is Good.